T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus (Q45797120)

16 December 2017

title

T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus (English)

1 reference

16 December 2017

0 references

Rickinson AB

1

1 reference

16 December 2017

publication date

1 January 1983

1 reference

16 December 2017

Progress in Brain Research

published in

1 reference

16 December 2017

volume

59

1 reference

16 December 2017

page(s)

189-202

1 reference

16 December 2017

A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell Activator

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Infectious mononucleosis: model for self-limiting lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Epstein-Barr (EB) Virus Genome-containing, EB Nuclear Antigen-negative B-lymphocyte Populations in Blood in Acute Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Various forms of Epstein-Barr virus infection in man: established facts and a general concept

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Recent progress in Epstein-Barr virus research

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Transformation Induced by Epstein-Barr Virus and the Role of the Nuclear Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivatedin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Antibody-Dependent Lymphocyte Cytotoxicity Against Cells Expressing Epstein—Barr Virus Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Epstein-barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Absence of infectious Epstein–Barr virus in blood in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Cell-Mediated Immunity to Epstein–Barr-Virus-Transformed Lymphoblastoid Cells in Acute Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Thymic origin of atypical lymphoid cells in infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Production of infectious Epstein–Barr virus in mouse lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n -Butyrate-Treated P3HR-1 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2963864-9

7 January 2021

10.1016/S0079-6123(08)63864-9

Identifiers

DOI

0 references

1 reference

16 December 2017